- 期刊
Management of skin toxicity related to the use of imatinib mesylate (STI571, Glivec^(TM)) for advanced stage gastrointestinal stromal tumours
摘要
Skin toxicity is a common side-effect of treatment with imatinib mesylate (STI571, Glivec^(TM)) in advanced gastrointestinal stromal tumours (GIST) and chronic myeloid leukaemia. The optimal duration of treatment with imatinib mesylate in GIST has not yet been established, as durable remissions have been observed in patients. It is, therefore, important to develop strategies to deal with common side-effects of what may be a long-term treatment. Here we report the case of a patient with advanced GIST who developed a cutaneous drug reaction secondary to imatinib mesylate and the various management options that may be employed depending upon the severity of the toxicity. The case and literature are discussed.
延伸閱讀
- 蔡嘉慧、陳永薇、陳寶純、邱燕甘（2022）。Reduce the incidence Rate of Medical Adhesive-Related Skin Injuries in pediatric cancer patients with Implanted Infusion Port。長庚護理，33(2)，56-69。https://doi.org/10.6386/CGN.202206_33(2).0006
- Good, L., & Burnett, B. P. (2015). Management of Loose, Frequent Stools and Fecal Incontinence in a Chronic Mesenteric Ischemia Patient with Oral Serum-derived Bovine Immunoglobulin. Clinical Medicine Insights: Gastroenterology, 2015(), 7-11. https://doi.org/10.4137/CGast.S21307
- JUDSON, I., LEAHY, M., WHELAN, J., LORIGAN, P., VERRILL, M., GRIMER, R., & ROBINSON, M. (2002). A guideline for the management of gastrointestinal stromal tumour (GIST). Sarcoma, 2002(), 83-87. https://doi.org/10.1080/1357714021000045217
- Wang, Y. Z., Sun, G., Cai, F. C., & Yang, Y. S. (2016). Clinical Features, Diagnosis, and Treatment Strategies of Gastrointestinal Diaphragm Disease Associated with Nonsteroidal Anti-Inflammatory Drugs. Gastroenterology Research and Practice, 2016(), 694-701-090. https://doi.org/10.1155/2016/3679741
- Shih, M. L., Hsieh, C. B., Yu, J. C., Lin, C. K., Chen, T. W., Kuo, Y. L., & Liu, Y. C. (2002). Successful Treatment of Metastatic Gastrointestinal Stromal Tumors Using Tyrosine Kinase Inhibitor STI571. Journal of Medical Sciences, 22(6), 323-325. https://www.airitilibrary.com/Article/Detail?DocID=10114564-200212-201305090027-201305090027-323-325